Company / SG&A per Share
Cytokinetics SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2366.89
FY2025
5-year range
$1.14 / $2366.89
FY2021-FY2025
Trend
+111628.0%
vs FY2024
Sector context
#2 of 210
Health Care
What the data says
SG&A per Share changed +111628% YoY in FY2025, a notable deviation from the 9-year average annual change of +12420%.
Based on SEC 10-K filings.
2366.89 in FY2025 with a 5-year CAGR of +401.8%. Ranks 2nd among 210 companies in Health Care.
Increased from $1.83 to $2366.89 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +940.9%
- 5-Year CAGR
- +401.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 210This company $2366.89 Sector average $40.75
▼
+5708.0% above sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 111628.0% year-over-year.
- Ranks #2 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2366.89 | +111628.0% |
| FY2024 | $2.12 | +15.7% |
| FY2023 | $1.83 | -12.8% |
| FY2022 | $2.10 | +83.9% |
| FY2021 | $1.14 | +53.5% |
| FY2020 | $0.74 | +11.1% |
| FY2019 | $0.67 | +17.1% |
| FY2018 | $0.57 | -15.4% |
| FY2017 | $0.68 | -1.3% |
| FY2016 | $0.68 | +37.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026